U.S. market Closed. Opens in 13 hours 24 minutes

MURA | Mural Oncology plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
RevenueN/AN/AN/A
Cost of Revenue2.57M1.54M1.47M
Gross Profit-2.57M-1.54M-1.47M
Operating Expenses192.07M195.15M175.37M
Selling, General & Admin30.04M25.08M15.55M
Research & Development162.03M170.07M159.82M
Other Operating ExpensesN/AN/AN/A
Operating Income-194.64M-195.15M-175.37M
Other Expenses / Income-649.00KN/AN/A
Before Tax Income-195.29M-195.15M-175.37M
Income Tax Expenses12.16M4.88M68.00K
Net Income-207.45M-200.03M-175.43M
Interest ExpensesN/AN/AN/A
Basic Shares Outstanding16.69M16.69M16.69M
Diluted Shares Outstanding16.69M16.69M16.69M
EBITDA-192.07M-193.61M-173.89M
EBITDA Margin0.00%0.00%0.00%
EBIT-195.29M-195.15M-175.37M
EBIT Margin0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙